A Possible Association between Deep Molecular Response and Combination of Tyrosine Kinase Inhibitor and Immunochemotherapy in a Patient with Coexisting Chronic Myeloid Leukemia and Follicular Lymphoma: A Case Report
Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of chronic myeloid leukemia (CML) and improved survival rates, however, concerns about TKI-related secondary malignancies persist. We report the case of a 55-year-old male with chronic phase CML who achieved a minimal molecular resp...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-04-01
|
| Series: | Journal of Cancer Research and Practice |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/ejcrp.eJCRP-D-25-00009 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|